NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 219 filers reported holding NPS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $213,371,000 | +39.2% | 5,965,074 | +1.2% | 0.02% | +25.0% |
Q3 2014 | $153,280,000 | -21.1% | 5,895,377 | +0.4% | 0.01% | -20.0% |
Q2 2014 | $194,159,000 | +13.9% | 5,874,715 | +3.2% | 0.02% | +7.1% |
Q1 2014 | $170,402,000 | +0.3% | 5,693,314 | +1.7% | 0.01% | -6.7% |
Q4 2013 | $169,960,000 | -2.2% | 5,598,146 | +2.5% | 0.02% | -11.8% |
Q3 2013 | $173,738,000 | +114.5% | 5,461,757 | +1.8% | 0.02% | +88.9% |
Q2 2013 | $81,004,000 | – | 5,364,426 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 549,425 | $16,680,000 | 6.89% |
Opaleye Management Inc. | 205,000 | $5,945,000,000 | 4.67% |
Rhenman & Partners Asset Management AB | 240,000 | $7,286,000 | 2.85% |
SECTORAL ASSET MANAGEMENT INC | 1,774,919 | $53,887,000 | 2.32% |
Eventide Asset Management | 242,700 | $7,368,000 | 2.27% |
OAK RIDGE INVESTMENTS LLC | 2,713,717 | $82,389,000 | 2.16% |
First Light Asset Management, LLC | 68,245 | $2,072,000 | 1.76% |
Broadfin Capital, LLC | 400,000 | $12,144,000 | 1.60% |
Cupps Capital Management, LLC | 748,175 | $22,714,000 | 1.54% |
FCG ADVISORS, LLC | 70,651 | $2,145,000 | 1.45% |